Galectin-9, a natural Tim-3 ligand [2, 5], demonstrated the ability to upregulate both mTOR kinase activity and HIF-1α accumulation in primary AML-PB001F blasts at levels comparable to those seen with anti-Tim-3. This evidence concerns the gene HAVCR2 and acute myeloid leukemia.